BioSpace News Archive

Axcella Therapeutics, a clinical-stage biotechnology company pioneering a new approach to treat complex diseases using multi-targeted endogenous metabolic modulator compositions, outlined key clinical and operational milestones that are expected for the company in 2022.

i2O Therapeutics, a developer of oral biologic products based on its proprietary ionic liquid platform, today announced a collaboration and option agreement with Janssen Biotech, Inc., for Janssen Research & Development to evaluate the use of ionic liquid technology for the oral delivery of macromolecules.

RenovoRx, Inc., a biopharmaceutical company and innovator in targeted cancer therapy, announced that Shaun Bagai, Chief Executive Officer, will participate in the H.C. Wainwright Bioconnect Virtual Conference on behalf of RenovoRx.

Sangamo Therapeutics, Inc. today announced that Sanofi will be transitioning its rights and obligations related to SAR445136.

Biofidelity, a pioneer in precision cancer diagnostics, has expanded its Scientific Advisory Board to include Lee N. Newcomer, MD.

Nexus Spine today announced key appointments to its leadership team that includes David Ivanko as Vice President of Quality Engineering and Manufacturing and Andrew Shepherd as Vice President of Marketing.

Twist Bioscience Corporation announced today an agreement with the Broad Institute to make available a whole exome target enrichment panel to enable next-generation sequencing (NGS) in canine genomics research.

BioSig Technologies, Inc., a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, announced that it it will present at the 24th Annual Virtual Needham Growth Conference on Friday, January 14th, 2022 at 4:15 PM ET.

Jnana Therapeutics will present a corporate overview at the 40th Annual J.P. Morgan Healthcare Conference on Thursday, January 13, 2022 at 10:30 a.m. ET.

Galapagos NV (Euronext & NASDAQ: GLPG) will participate in the40th Annual J.P. Morgan Healthcare Conference on January 10-13, 2022.